NASDAQ:LYRA
Lyra Therapeutics Inc. Stock News
$0.383
+0.0154 (+4.19%)
At Close: May 17, 2024
New SEC Disclosure: What Should You Do With The Form CRS That Just Came In The Mail?
12:00am, Thursday, 06'th Aug 2020
The SEC proposed this document to make life easier for investors to understand services and compare firms — and I believe it will. Let me tell you why.
Lyra Therapeutics Reports Second Quarter 2020 Financial Results and Provides Corporate Update
08:05pm, Wednesday, 05'th Aug 2020
\- On track to report topline Phase 2 results for LYR-210 in chronic rhinosinusitis in 4Q 2020 - \- Conference call and webcast today at 4:30 p.m. ET -WATERTOWN, Mass., Aug. 05, 2020 (GLOBE NEWSWIRE)
The Daily Biotech Pulse: Novavax Vaccine Data, Aerpio Gets $5.1M Funding For COVID Trial, Rigel Gains Big On Earnings
12:00am, Wednesday, 05'th Aug 2020
Scaling The Peaks
(Biotech Stocks Hitting 52-week Highs Aug. 4)
ABIOMED, Inc. (NASDAQ: ABMD) (FDA approved the emergency use of Abiomed's Impella heart pump in combination...
Lyra Therapeutics to Present at the BTIG Virtual Biotechnology Conference
08:05pm, Tuesday, 04'th Aug 2020
WATERTOWN, Mass., Aug. 04, 2020 (GLOBE NEWSWIRE) -- Lyra Therapeutics, Inc. (Nasdaq: LYRA), a clinical-stage therapeutics company focused on the development and commercialization of novel integrated d
Lyra Therapeutics Announces Pamela Nelson as Senior Vice President of Regulatory Affairs
12:00pm, Tuesday, 04'th Aug 2020
WATERTOWN, Mass., Aug. 04, 2020 (GLOBE NEWSWIRE) -- Lyra Therapeutics, Inc. (Nasdaq: LYRA), a clinical-stage therapeutics company focused on the development and commercialization of novel integrated d
We're Hopeful That Lyra Therapeutics (NASDAQ:LYRA) Will Use Its Cash Wisely
06:40pm, Monday, 03'rd Aug 2020
We can readily understand why investors are attracted to unprofitable companies. For example, biotech and mining...
The Week Ahead In Biotech: Novavax Coronavirus Vaccine Readout, FDA Decisions And More Earnings
12:00am, Sunday, 02'nd Aug 2020
Biotech stocks came under pressure in the week ended July 31 amid mixed earnings from the sector and some adverse clinical readouts.
COVID-19 news flow continued to pour in,...
Lyra Therapeutics to Participate in Fireside Chat at the William Blair Biotech Focus Conference
08:05pm, Thursday, 30'th Jul 2020
WATERTOWN, Mass., July 30, 2020 (GLOBE NEWSWIRE) -- Lyra Therapeutics, Inc. (Nasdaq: LYRA), a clinical-stage therapeutics company focused on the development and commercialization of novel integrated d
Lyra Therapeutics to Report Second Quarter 2020 Financial Results and Provide Corporate Update
12:30pm, Friday, 24'th Jul 2020
WATERTOWN, Mass., July 24, 2020 (GLOBE NEWSWIRE) -- Lyra Therapeutics, Inc. (Nasdaq: LYRA), a clinical-stage therapeutics company focused on the development and commercialization of novel integrated d
Lyra Therapeutics Announces Robert Richard, Ph.D., as Senior Vice President of Research and Development
12:30pm, Tuesday, 07'th Jul 2020
Lyra Therapeutics, Inc. (LYRA), a clinical-stage therapeutics company focused on the development and commercialization of novel integrated drug and delivery solutions for the localized treatment of pa
Lyra Therapeutics Set to Join the Russell 2000® Index and Russell 3000® Index
12:00pm, Thursday, 25'th Jun 2020
Lyra Therapeutics, Inc. (LYRA), a clinical-stage therapeutics company focused on the development and commercialization of novel integrated drug and delivery solutions for the localized treatment of pa
Lyra Therapeutics, e.l.f. Beauty, and Avid Tech See Activist Action
11:25pm, Friday, 05'th Jun 2020
Impactive Capital increased its stake in Avid Technology, a maker of digital-media platforms including Pro Tools. Marathon Partners disclosed a large stake in cosmetics retailer e.l.f. Beauty.
Lyra Therapeutics Reports First Quarter 2020 Financial Results and Provides Corporate Update
08:05pm, Thursday, 28'th May 2020
WATERTOWN, Mass., May 28, 2020 -- Lyra Therapeutics, Inc. (Nasdaq: LYRA), a clinical-stage therapeutics company focused on the development and commercialization of novel.
Lyra Therapeutics to Present at the Jefferies Virtual Global Healthcare Conference
12:00pm, Thursday, 28'th May 2020
Lyra Therapeutics to Present at the Jefferies Virtual Global Healthcare Conference
Lyra Therapeutics to Present at the Bank of America Merrill Lynch Virtual Global Healthcare Conference
12:00am, Saturday, 09'th May 2020
Lyra Therapeutics to Present at the Bank of America Merrill Lynch Virtual Global Healthcare Conference
